Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991

Neuroscience and Biobehavioral Reviews

Volumn 17, Issue 1, 1993, Pages 21-41

  Schechter, Martin D ^a   Calcagnetti, Daniel J ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Conditioned place preference; Drug affect; Place approach; Rats

Indexed keywords

AVOIDANCE BEHAVIOR; CONDITIONING; DOSE RESPONSE; HEALTH SURVEY; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLICATION; REVIEW; TASK PERFORMANCE;

ANIMAL; CHOICE BEHAVIOR; CONDITIONING, OPERANT; PSYCHOLOGY, EXPERIMENTAL;

EID: 0027461527     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(05)80228-3     Document Type: Article

References (350)

1. Effects of apomorphine on novelty-induced place preference behavior in rats
2. Single-trial conditioned place preference using intravenous morphine
3. Morphine addiction in rats
4. Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage
5. Conditioned place preference: an evaluation of morphine's positive reinforcing properties
6. Reducing the time needed to conduct conditioned place preference testing
7. Place conditioning reveals the rewarding aspect of social interaction in juvenile rats
8. The effects of alcohol on conflict behavior in the albino rat
9. The effects of progabide (SL 76002) on locomotor activity and conditioned place preference induced by d-ampetamine
10. Spatial avoidance in the rat as a result of exposure to ionizing radiation
11. Dynorphin A (1-17) induces “reward” in rats in the place conditioning paradigm
12. Naloxone disrupts the expression but not the acquisition by male rats of a conditioned place preference response for an oestrous female
13. Drug reinforcement studied by the use of place conditioning in rats
14. Affective states associated with morphine injections
15. Drug discrimination procedure: a bibliography
16. Trends in drug discrimination research analyzed with a cross-index bibliography, 1984–1987
17. Reward or reinforcement: What's the difference?
18. The psychobiology of reinforcers
19. The brain and reward
20. Morphine-6-glucuronide contributes to rewarding effects of opiates
21. 14C]-2-deoxyglucose study
22. SCH 23390 blocks drug-conditioned place-preference and place aversion: anhedonia (lack of reward) and apathy (lack of motivation) after dopamine-receptor blockade?
23. Evidence of place conditioning after chronic intrathecal morphine in rats
24. Reinforcing properties of ejaculation in the male rat: role of opioids and dopamine
25. Rewarding properties of β-endorphin as measured by conditioned place preference
26. A multi-dimensional examination of the positive reinforcing properties of acetaldehyde
27. Clonidine produces a conditioned place preference in rats
28. Conditioned place preference and ethanol
29. Failure to establish a conditioned place preference with ethanol in rats
30. Rewarding effects of amphetamine and cocaine in the nucleus accumbens and block by flupenthixol
31. Evidence that the aversive effects of opioid antagonists and k-agonists are centrally mediated
32. Involvement of central μ and d opioid receptors in mediating the reinforcing effects of β-endorphin in the rat
33. The role of β-endorphin (1–27) in reinforcement
34. Role of D1 and D2 subtypes of dopamine receptors in novelty-induced place preference
35. Effects of apomorphine on novelty-induced place preference behavior in rats
36. conditioned place preference with morphine: the effect of extinction training on the reinforcing CR
37. Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine
38. Single-trial conditioned place preference using intravenous morphine
39. Repeated testing attenuates conditioned place preference with cocaine
40. Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs
41. Place conditioning with morphine and phencyclidine: dose dependent effects
42. Conditioned place preference (CPP) produced by intranigral morphine
43. Morphine addiction in rats
44. Kappa receptors mediate the peripheral aversive effects of opiates
45. Separation of morphine's incentive motivational from its escape from withdrawal properties
46. Peripheral receptors mediate the aversive conditioning effects of morphine in the rat
47. Are aversive effects of ethanol blocked by peripheral opioid antagonists?
48. Interactive effect of cocaine and caffeine as assessed by conditioned place preference
49. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning
50. Conditioned aversion to distinct environmental stimuli resulting from gastrointestinal distress
51. MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids
52. Methylenedioxy-methamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage
53. Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference
54. MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference
55. MDMA's effects establish a conditioned place preference and elicit signs of sexual arousal among rats
56. A preference in rats for cues associated with intoxication
57. Conditioned place preference: an evaluation of morphine's positive reinforcing properties
58. A computer approach to measuring shuttle box activity and conditioned place preference
59. Evidence for the rewarding effects of ethanol using the conditioned place preference method
60. Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats
61. Dissociation of the rewarding and physical dependence-producing properties of morphine
62. Dopaminergic mediation of opiate reward
63. Heroin reward is dependent on a dopaminergic substrate
64. Differential effects of A1 and A2 adenosine receptor antagonists on place conditioning and motor activity in rats
65. Caffeine-induced conditioned place preference and aversion
66. Caffeine-induced place and taste conditioning: Production of dose-dependent preference and aversion
67. Behavioral and neurochemical interactions between cocainse and buprenorphine: implications for pharmacotherapy of cocaine abuse
68. Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for pharmacotherapy of cocaine abuse
69. Conditioned place aversion following the central administration of a novel dopamine release inhibitor, CGS 10746B
70. 3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward
71. Behavioral independence of amphetamine reward and locomotor stimulation demonstrated by conditioned place preference
72. Independence of amphetamine reward from locomotor stimulation demonstrated by conditioned place preference
73. Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study
74. Conditioned place preference from intra-accumbens but not caudate or amygdala amphetamine injections
75. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections
76. Apparent absence of nicotine-induced conditioned place preference in rats
77. 6-hydroxydopamine lesions of the olfactory tubercle do not alter (+)-amphetamine-conditioned place preference
78. Conditioned place preference induced by ethanol in a rat line selected for ethanol preference
79. Conditioned place preference produced by intra-hippocampal morphine
80. Amphetamine induced conditioned place aversion in female Long-Evans rats
81. Dose-dependent and baseline-dependent conditioning in the place preference paradigm
82. Environmental cues influence cocaine- and procaine-mediated place preference
83. Flavor and location aversions produced by ethanol
84. Spatial aversion conditioning with ethanol
85. Assessment of ethanol's hedonic effects in mice selectively bred for sensitivity to ethanol-induced hypothermia
86. Tolerance to the aversive but not to the rewarding effect of ethanol
87. Genetic differences in ethanol-induced place-preference conditioning
88. Ethanol-induced conditioned place preference in mice selectively bred for insensitivity to ethanol hypothermia
89. Conditioning of activity and place preference by ethanol
90. Ethanol-induced conditioned place preference in mice: role of conditioning trial duration
91. Novel versus familiar ethanol: a comparison of aversive and rewarding properties
92. Luteinizing hormone releasing hormone-induced conditioned place-preference in male rats
93. Rewarding properties of LHRH revealed by conditioned place preference in male rats
94. Sex differences in luteinizing hormone releasing hormone-induced conditioned place preference in the rat
95. Estradiol-induced conditioned taste aversion and place aversion in rats: sex- and dose-dependent effects
96. Preference and aversion for brain stimulations estimated by the conditioned place preference
97. The conditioned place preference and intracranial rewarding stimulation and intraperitoneal injection of ethanol
98. The effects of progabide (SL 76002) on locomotor activity and conditioned place preference induced by d-amphetamine
99. Conditioned place aversion produced by FG 7142 is attenuated by haloperidol
100. Conditioned place aversion produced by microinjections of semicarbazide into the periaqueductal gray of the rat
101. Low-dose ethanol treatment potentiates d-amphetamine-produced conditioned place preference
102. Dose-response effects of methamphetamine-produced location preference
103. Effects of haloperidol on conditioned place preferences produced by electrical stimulation of medial prefrontal cortex
104. Haloperidol attenuates conditioned place preferences produced by electrical stimulation of the medial prefrontal cortex
105. Haloperidol blocks conditioned place preferences induced by rewarding lateral hypothalamic stimulation in rats
106. Haloperidol prevents the establishment of brain stimulation induced conditioned place preferences but not aversions in rats
107. Locus coeruleus stimulation-induced place preferences are prevented by pretreatment with the dopamine antagonist pimozide
108. Opiate reinforcement and naloxone aversion, as revealed by place preference paradigm, in two strains of rats
109. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion
110. The assessment of the organizing influence of amphetamine on behavior: interaction between place preference and taste aversion
111. Haloperidol blocks the conditioned place preferences induced by rewarding brain stimulation
112. Animal model for investigating the anxiogenic effects of self-administered cocaine
113. Aversive properties of vasopressin may account for its putative role in memory
114. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
115. The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes
116. Ethanol-induced place preference in naive alcohol-preferring rats
117. Aversive and appetitive properties of anxiogenic and anxiolytic agents
118. Fentanyl-induced conditional place preference: lack of associated conditional neurochemical events
119. The calcium antagonist isradipine inhibits cocaine and morphine reinforcing properties in rats
120. Conditioned aversion after delay place conditioning with nicotine
121. Further studies on nicotine-induced conditioned place preference in the rat
122. Nicotine(NIC)-induced conditioned place preference (CPP): dose-response, temporal requirements and lack of tolerance development
123. Pharmacologic characterization of nicotine-induced condition place preference
124. A new opioid analgestic KT90: analgesia and dependence liability
125. Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats
126. Motivational properties of morphine in naive and morphine dependent rats
127. Naloxone and morphine reinforcing properties revealed by place conditioning in rats: evidence of addictive effects
128. Spatial avoidance in the rat as a result of exposure to ionizing radiation
129. Pentylenetetrazole can induce a conditioned place preference
130. Historical factors in the development of ETOH-conditioned place preference
131. Cocaine-induced place preferences: effects of alterations in length of neutral zone on test day
132. β-phenylethylamine, d-amphetamine- and 1-amphetamine-induced place preference conditioning in rats
133. Dopamine and reward: conditioned place preference induced by dopamine D2 receptor agonist
134. Phencyclidine (PCP) generates conditioned reinforcement in the nucleus accumbens (ACC) but not in the ventral tegmental area (VTA)
135. Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain
136. Neurotensin: a new “reward peptide.”
137. Rewarding effects of neurotensin in the brain
138. Dopamine blockade in nucleus accumbens reduces bar-press but not place preference measures of LH stimulation reward
139. Differential mechanism in the acquisition and expression of heroin-induced place preference
140. Conditioned place preference in the corral: a procedure for measuring reinforcing properties of drugs
141. Modification of place preference conditioning in mice by systemically administered [Leu]enkephalin
142. Neuropharmacological assessment of cocaine-induced conditioned place preference using intra-cranial microinjections
143. The relative contribution of peripheral and central components in cocaine-induced place conditioning
144. Gestational exposure to cocaine decreases sensitivity to the rewarding properties of cocaine in infant rat pups
145. 3 receptor antagonists on behavioral indices of morphine reward and withdrawal
146. B antagonist against morphine conditioned place preference (CPP)
147. Involvement of the lateral nucleus of the amygdala in amphetamine and food conditioned place preferences (CPP)
148. Effects of alpha-methyl-para-tyrosine on the maintenance of conditioned place preference
149. Effects of dopamine antagonists on acquisition and expression of the amphetamine conditioned place preference
150. The amphetamine conditioned place preference: differential involvement of dopamine receptor sybtypes and two dopaminergic terminal areas
151. The effects of pimozide on the establishment of conditioned reinforcement as a function of the amount of conditioning
152. The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats
153. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning
154. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences
155. Reinforcing properties of substance P in the lateral hypothalamus revealed by conditioned place preference
156. Reinforcing properties of substance P in the region of the nucleus basalis magnocellularis in rats
157. Opioid mediation of cocaine-induced hyperactivity and reinforcement
158. Comparative effects of preoptic area infusions of opioid peptides, lesions and castration on sexual behavior in male rats: studies of instrumental behavior, conditioned place preference and partner preference
159. The role of self- and other-animal-produced odors in rats' preferences for novelty in an exploration box
160. Isolation versus grouped housing in rats: differential effects of low doses of heroin in the place preference paradigm
161. Assaying addiction liability of opioids
162. Selected opioids, pressing for intracranial stimulation, and the conditioned place preference test
163. The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P
164. Mesocortical dopamine system lesions disrupt cocaine reinforced conditioned place preference
165. Characterization of dynorphin A (1–17)-induced place preference in rats
166. Dynorphin A (1–17) place preference in rats: opioid-specific and dopaminergic
167. Dynorphin A (1–17) induces “reward” in rats in the place conditioning paradigm
168. Nicotine conditions place preferences after intracerebral administration in rats
169. Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism
170. Place-conditioning properties of mu, kappa, and sigma opioid agonists
171. Nicotine actions in models of learning/memory and reward
172. Place-conditioned aversion induced by nicotine (NIC) after delay conditioning
173. Aversion instead of preference learning indicated by nicotine place conditioning in rats
174. Intra-accumbens neuropeptide Y produces reward: a conditioned place preference that is blocked by pre-treatment with a dopamine antagonist
175. A rapid and inexpensive technique for assessing the reinforcing effects of opiate drugs
176. Lesions of the nucleus accumbens in rats reduce opiate reward but do not alter context-specific opiate tolerance
177. Reinforcing properties of morphine chronically used in aversive life conditions: place-preference paradigm, long-term changes in behavioral reactivity
178. Neurochemical substrates for opiate reinforcement
179. Chronic buprenorphine attentuates cocaine place preference
180. Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment
181. Different effects of zimelidine on the reinforcing properties of d-amphetamine and morphine on conditioned place preference in rats
182. Morphine dependence in rats: secondary reinforcement from environmental stimuli
183. Position preference based on differential food privation
184. Lithium Chloride and avoidance of novel places
185. A comparison of the rewarding properties of “free” versus “earned” amphetamine
186. Magnesium-induced conditioned place preference in mice
187. Post-conditioning drug effects on conditioned place preference induced by the coadministration of magnesium and cocaine
188. Post-conditioning effects of magnesium on cocaine conditioned place preference in mice
189. Effects of intra-accumbens injection of the glutamate antagonist DNQX on place preference and locomotor activity induced by amphetamine
190. Different mechanisms underlie the acquisition and expression of heroin-induced place preference
191. Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning
192. Amphetamine produces a higher place preference if the place-sickness association is blocked by a taste
193. Enhancement of conditioned preference for a place paired with amphetamine produced by blocking the association between place and amphetamine-induced sickness
194. Ingestion of sweet water enhances the rewarding effect of morphine in rats
195. Effects of the competitive NMDA antagonist CPP on performance of a place cue radial maze task
196. Scopolamine blockade of amphetamine-induced CPP
197. Visceral cortex lesions block conditioned taste aversions induced by morphine
198. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning
199. Neuroleptics do not block the reinforcing effects of opiates in the conditioned place preference paradigm
200. Ethanol with small doses of morphine establishes a conditioned place preference
201. PCP and conditioned place preferences
202. Morphine preexposure attentuates the aversive properties of opiates without pre-exposure to the aversive properties
203. The perception of emotion: parallel neural processing of the affective and discriminative properties of opiates
204. Spatial avoidance in a paradigm in which ionizing irradiation precedes spatial confinement
205. Conditioned aversion in spatial paradigms following methamphetamine injection
206. Intra-accumbens methylphenidate injections fail to produce place preference conditioning
207. Lack of attentuation of methylphenidate-conditioned place preferences by haloperidol
208. Place preference conditioning with methylphenidate and nomifensine
209. The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum
210. Preference paradigm: provides better self-stimulation reward discrimination than a rate-dependent paradigm
211. Naloxone disrupts the expression but not the acquisition by male rats of a conditioned place preference response for an oestrous female
212. Aversive properties of bombesin in the conditioned place-preference paradigm in rats
213. Aversive properties of bombesin in rats
214. Conditioned place preference for cocaine in rats: open test with known expected baseline choice values
215. Naloxone inhibits mating and conditioned place preference for an estrous female in male rats soon after castration
216. The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity
217. Conditioned place preference induced by intracerebroventricular microinjections of cocaine: possible involvement of central dopamine
218. Dopaminergic substrates of cocaine-induced place conditioning
219. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated with-drawal? A place conditioning study in the rat
220. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
221. Preference conditioning produced by opioid active and inactive isomers of levorphanol and morphine in rat
222. Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination
223. Opiate with-drawal motivation reflected in defensive burying: validation of the preference conditioning model
224. Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central β-endorphin
225. Kappa and mu opioid receptor agonists have different motivational properties as revealed by place and taste preference conditioning
226. Drug reinforcement studied by the use of place conditioning in rat
227. Conditioned preference produced by injection of glutamate into the antero-lateral hypothalamus
228. Conditioned place reference (CPP) induced by ventral tegmental area (VTA) injections of the nicotinic agonist cytisine
229. Neuroleptics block high dose, but not low dose, heroin conditioned place preferences
230. Reinforcing properties of drinking water: Role of opioids and dopamine
231. Conditioned taste aversion and place preference with buspirone and gepirone
232. Cocaine-induced place conditioning: importance of route of administration and other procedural variables
233. Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats
234. The post-conditioning drug test: a potential useful procedure for acquisiton of conditioned place aversion
235. 6-SP6-11 in the rat
236. Effects of pedunculopontine tegmental nucleus lesions on morphine induced conditioned place preference and analgesia in the formalin test
237. The conditioned place preference paradigm in rats: Effect of bupropion
238. Isradipine inhibition of cocaine conditioned place preference
239. The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine
240. Acute imipramine treatment enhances a conditioned place preference for cocaine in a novel test
241. Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats
242. Differential effects of short- and long-term antidepressant treatments on the food-induced place preference conditioning in rats
243. Blockade of 8-OH-DPAT-induced place preference but not place aversion by DA antagonists of PCPA
244. 8-OH-DPAT-induced place preference and place aversion: Effects of PCPA and dopamine antagonists
245. An animal model of anhedonia: Attentuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
246. The receptor organization of the reinfocing and analgetic opiate systems in the rat
247. Triazolam attenuates amphetamine but not morphine conditioned place preferences
248. VTA microinfusions of (S)-cholecystokinin octapeptide potentiate amphetamine conditioned place preferences
249. Reinforcing effects of morphine microinjections into the ventral tegmental area
250. 5-enkephalinamide into the ventral tegmental area
251. Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of the rat
252. Conditioned place preference with amphetamine and opiates as reward stimuli: attentuation by haloperidol
253. Morphine place-preference: examination of the paradigm and its associative properties
254. Location preference and flavor aversion reinforced by amphetamine in rats
255. Toward understanding ethanol's capacity to be reinforcing: a conditioned place preference following injections of ethanol
256. Measuring morphine's capacity to establish a place preference
257. Opioids' enhancement of intake of ethanol is related to their inducement of place preferences (reward) but not of their nociception (analgesia)
258. Ethanol-induced conditioned place preference eliminated by temporal delay
259. Effect of RO 15-4513 on ethanol-induced conditioned place preference
260. Active avoidance conditioning with dorsal central gray stimulation in a place preference paradigm
261. Disruption of the connections between the mediodorsal and sulcal prefrontal cortices alters the associability of rewarding medical cortical stimulation to place and taste stimuli in rats
262. Conditioned place aversion with lithium chloride does a test under lithium chloride potentiate learning?
263. Naloxone administration following brief exposure to novelty reduces activity and rearing in mice upon 24-h retest: a conditioned aversion?
264. Morphine administered to the ventral tegmental area produces place preference conditioning in the neonatal rat
265. Affective states associated with morphine injections
266. ESB of lateral hypothalamic fear/flight sites in rats produces conditioned place avoidance
267. Effect of learned behavior upon conditioned place preference to cathinone
268. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination
269. Effect of repeated administrations upon cathinone discrimination and conditioned place preference
270. An examination of heroin conditioning in preferred and nonpreferred environments and in differentially housed mature and immature rats
271. Isolation versus grouped housing in rats: differential effects of low doses of heroin in the place preference paradigm
272. Cocaine conditioning in the place preference paradigm: effects of environmental rearing conditions
273. Differential effects of isolation housing on the conditioned place preference produced by cocaine and amphetamine
274. Morphine conditioned place preference in the hamster
275. Depression of morphine seeking-behavior by dopamine inhibition
276. A potential role of saline trials in morphine-induced place-preference conditioning
277. Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine
278. Rewarding and aversive effects of morphine: temporal and pharmacological properties
279. Temporal properties of the rewarding and aversive effects of amphetamine in rats
280. Alterations in the motivational effects of opioids following proglonged pain: involvement of the mesolimbic system
281. Motivational properties of opioids: evidence that an activation of d-receptors mediates reinforcement processes
282. Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity
283. Biphasic motivational properties of partial opioid agonists: role of μ- and k-opioid receptors
284. Motivational effects of opioid agonists and antagonists: mediation by DA-1 but not DA-2 receptors
285. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and k-opioid agonists
286. Involvement of β-endorphin and μ-opioid receptors in mediating the aversive effects of lithium in the rat
287. Motivational effects of 5-HT1 receptor agonists: Place conditioning and in-vivo microdialysis studies
288. Independence of conditioned place preferences and activity in rats
289. Place avoidance learning and stress-induced analgesia in the attacked mouse: role of endogenous opioids
290. Place avoidance learning in the attacked DBA/2 mouse mediated by endogenous opioids
291. Conditioned place preference induced by intraventricular infusions of acetaldehyde
292. β-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens
293. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam
294. Attenuation by haloperidol of place preference conditioning using food reinforcement
295. Attentuation of heroin reward in rats by disruption of the mesolimbic dopamine system
296. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamien lesions
297. Dopaminergic substrates of amphetamine-induced place preference conditioning
298. Diazepam-induced place preference conditioning: appetitive and antiaversive properties
299. Social relationship-induced place preference behavior in rats
300. Drug-induced place preference in rats with 5,7-dihydroxy-tryptamine lesions of the nucleus accumbens
301. Intravenous cocaine-induced place preference: attenuation by haloperidol
302. 2-methionine enkephalin
303. Central action of substance P: possible role in reward
304. The representation in memory of morphine's unconditioned motivational effects depends on the nature of the conditioned stimulus
305. Changes in sensitivity to apomorphine following repeated morphine injections are specifically related to the place where morphine is experienced
306. The non-competitive NMDA antagonist, MK801, blocks the development of conditioned activity to amphetamine (AMPH)
307. An investigation of the interaction between the reinforcing properties of food and ethanol using the place preference paradigm
308. Conditioned place aversion mediated by orally self-administered ethanol in the rat
309. Conditioned place aversion mediated by self-administered ethanol in the rat: a consideration of blood ethanol levels
310. Chronic flupenthixol treatment potentiates the reinforcing properties of systemic heroin administration
311. Dependence on opioids in mu receptor deficient (CXBK) mice
312. Pertussis toxin abolishes μ- and d-opioid agonist-induced place preference
313. Drug interactions in the reinforcing effects of over-the-counter cough syrups
314. Studies on drug dependence (Rept.169): drug interaction in the reinforcing properties of over-the-counter (OTC) cough syrups
315. Studies on drug dependence (Rept. 185): drug interactions of psychostimulants with other drugs in appetitive effects in rats
316. Potentiation of pentazocine conditioned place preference by tripelennamine in rats
317. Morphine conditioned place preference after chronic treatment with naloxone in the rat
318. Studies on drug dependence (Rept.186): enhancement of morphine conditioned place preference after chronic treatment with naloxone in the rat
319. The dopamine (D3-preferring) autoreceptor antagonists (+)-AJ76 and (+)-UH232 produce conditioned place-preference in the rat
320. Restrained rats learn amphetamine-conditioned locomotion, but not place preference
321. Electrolytic lesions of the substantia innominata and lateral preoptic area attentuate the ‘supersensitive’ locomotor response to apomorphine resulting from denervation of the nucleus accumbens
322. Cholecystokinin produces conditioned place-aversions, not place-preferences in food-deprived rats: evidence against involvement in satiety
323. Antinociception induced by stimulation of the habenular complex of the rat
324. Effects of two alpha 2 agonists, rilmenidine and clonidine, on the morphine withdrawal syndrome and their potential addictive properties in rats
325. Establishment of secondary reinforcement in sign tracking and place preference tests following pimozide treatment
326. Secondary reinforcement based on primary brain stimulation
327. Naloxone blockade of amphetamine place preference conditioning
328. Naloxone blockade of amphetamine reward in place preference conditioning
329. Anxiogenic effects of β-CCE as measured in two different conditioning paradigms
330. Reinforcing effects of brain microinjections of morphine revealed by condition place preference
331. Motivational properties of ethanol in naive rats as studied by place conditioning
332. Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions
333. Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field
334. Morphine conditioned place preference and locomotion: the effect of confinement during training
335. Strong absolute conditioned place preference is obtained when morphine is paired exclusively with tactile stimuli in an open field
336. Place conditioning with d-amphetamine: the effect of CS-UCS interval and evidence of a place avoidance
337. Place conditioning with d-amphetamine: evidence of an aversion
338. Cocaine injected ICV produces place preference conditioning in the neonatal rat
339. Both memory and reward influence the place preference test
340. The conditioned place preference is affected by two independent reinforcement processes
341. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens
342. Evidence for simultaneous anxiolytic and aversive effects several hours after administration of sodium phentobarbitone to the rat
343. Cholinergic involvement in lateral hypothalamic rewarding brain stimulation
344. The dopamine innervation of the visceral cortex mediates the aversive effects of opiates
345. Secondary-reinforcing effects of opiate agonists in the mouse
346. Reinforcing, but no analgesic, effect of opiate stimulation of the ventral tegmental area